ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,832Medicare Part D Prescriptions Filled, Including Refills

Rank: 1385 out of 5176

$513K Total Retail Price of All Prescriptions

Rank: 1115 out of 5176

383 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 6,313 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 362 333 1 4
ATORVASTATIN CALCIUM 359 345 2 9
PRAVASTATIN SODIUM 246 220 3 23
OMEPRAZOLE 234 223 4 3
HYDROCHLOROTHIAZIDE 211 194 5 10
LISINOPRIL 189 183 6 5
LOSARTAN-HYDROCHLOROTHIAZIDE 151 136 7 35
AMLODIPINE BESYLATE 140 127 8 2
SIMVASTATIN 137 133 9 1
GABAPENTIN 127 122 10 21
HYDROCODONE-ACETAMINOPHEN 123 99 S3 11 27
FLUTICASONE PROPIONATE 117 108 12 38
MELOXICAM 116 107 13 53
METFORMIN HCL 108 99 14 7
ZOLPIDEM TARTRATE 104 89 15 17
CRESTOR 103 86 16 15
LANSOPRAZOLE 100 99 17 113
BENAZEPRIL HCL 94 94 18 131
ATENOLOL 81 77 19 12
FUROSEMIDE 79 78 20 8
FINASTERIDE 79 77 20 69
METOPROLOL SUCCINATE 79 73 20 11
METOPROLOL TARTRATE 79 75 20 6
WARFARIN SODIUM 78 78 24 13
DONEPEZIL HCL 77 77 25 28
NAMENDA 77 77 25 47
CELEBREX 76 76 27 80
CITALOPRAM HBR 72 57 28 31
FAMOTIDINE 72 69 28 58
SERTRALINE HCL 70 70 30 30
DIOVAN 67 64 31 19
LOSARTAN POTASSIUM 66 48 32 14
GLIMEPIRIDE 65 51 33 37
TAMSULOSIN HCL 64 64 34 20
PANTOPRAZOLE SODIUM 62 53 35 61
SPIRIVA 57 55 36 54
CARVEDILOL 53 53 37 24
ADVAIR DISKUS 50 43 38 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.